Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 46
Filter
1.
Mem. Inst. Invest. Cienc. Salud (Impr.) ; 17(2): 77-85, ago. 2019. tab, ilus
Article in Spanish | LILACS, BDNPAR | ID: biblio-1008512

ABSTRACT

La endoftalmitis infecciosa es una condición intraocular grave, aunque poco frecuente, que puede llevar a la pérdida de la visión. El diagnóstico etiológico precoz y el tratamiento adecuado llevan a una mejor evolución. Las técnicas microbiológicas convencionales tienen baja sensibilidad en el diagnóstico de la endoftalmitis infecciosa, en cambio la reacción en cadena de la polimerasa (PCR) es un método de mayor sensibilidad que está siendo utilizado ampliamente. El objetivo fue determinar por cultivo y PCR la etiología de la endoftalmitis infecciosa en pacientes que consultaron en centros oftalmológicos de Paraguay. Se estudiaron muestras de humor vítreo obtenidas por punción de 51 pacientes con endoftalmitis. La muestra se dividió en dos alícuotas; una para el estudio microbiológico convencional y la otra para la PCR anidada. Esta última utiliza un par de cebadores basado en secuencias conservadas del gen 16S ribosomal y cebadores específicos para bacterias gram positivas. Se estandarizó la PCR logrando una sensibilidad de detección de 3.10-5 ng/µl para S. aureus, 2,5.10-3 ng/µl para S. pneumoniae y 6.10-7 ng/µl para E. coli. De las 51 muestras, 12 (23,5%) fueron positivas por métodos microbiológicos convencionales y 26 (51,0%) por la PCR anidada. Por cultivo se identificaron predominantemente bacterias grampositivas 8/11 (73%) y un aislado de hongo filamentoso. La PCR anidada presentó muy buena sensibilidad y de gran utilidad en la identificación del origen bacteriano de la endoftalmitis, mejorando la sensibilidad del cultivo en 27,5%. La discriminación bacteriana en grampositivos y gramnegativos por la PCR se correlacionó con el cultivo en el 100% de los casos(AU)


Subject(s)
Humans , Male , Female , Adult , Middle Aged , Aged , Endophthalmitis/microbiology , Polymerase Chain Reaction , Endophthalmitis/diagnosis , Cross-Sectional Studies , Sensitivity and Specificity , Gram-Positive Bacteria/genetics
2.
Arq. bras. oftalmol ; 82(1): 25-31, Jan.-Feb. 2019. tab
Article in English | LILACS | ID: biblio-973871

ABSTRACT

ABSTRACT Purpose: To compare effects of 5% topical povidone iodine with prophylactic topical azithromycin and moxifloxacin on bacterial flora in patients undergoing intravitreal injection. Methods: A total of 132 patients were randomly assigned to receive treatment with azithromycin or moxifloxacin, or no treatment (control group). In total, 528 specimens were obtained at the time of admission, 4 days before intravitreal injection, 4 days after intravitreal injection, and 8 days after intravitreal injection. Samples were immediately sent to the microbiology laboratory for incubation. Results: The microorganism observed most frequently was coagulasenegative Staphylococcus (23.8%). When the results of samples obtained on Day 4 before injection were assessed, growth of coagulase-negative Staphylococcus was significantly lower in the moxifloxacin group, compared with controls (p=0.049). Acinetobacter baumannii continued to grow after administration of azithromycin (p=0.033). When the results of four days after intravitreal injection were evaluated, growth of coagulase-ne gative Staphylococcus was higher in controls, compared with patients who received azithromycin or moxifloxacin (p=0.004). Eradication rate was significantly higher in the moxifloxacin group than in the control group (p=0.001). Samples obtained on Day 8 after intravitreal injection showed similar levels of bacterial growth in all groups (p=0.217). Conclusion: Moxifloxacin was more effective than 5% povidone iodine in controlling the growth of conjunctival bacterial flora. Use of moxifloxacin in combination with 5% povidone iodine resulted in a synergistic effect.


RESUMO Objetivo: Comparar os efeitos de iodopovidona tópico a 5% com azitromicina e moxifloxacina profiláticas sobre a flora bacteriana em pacientes submetidos à injeção intravítrea. Métodos: Um total de 132 pacientes foram aleatoriamente designados para receber tratamento com azitromicina ou moxifloxacina ou nenhum tratamento (grupo controle). No total, 528 amostras foram obtidas no momento na admissão, 4 dias antes da injeção intravítrea, 4 dias após a injeção intravítrea e 8 dias após a injeção intravítrea. As amostras foram imediatamente enviadas para o laboratório de microbiologia para incubação. Resultados: O microorganismo mais frequentemente observado foi o Staphylococcus coagulase-negativo (23,8%). Quando os resultados das amostras obtidas no dia 4 antes da injeção foram avaliados, o crescimento do Staphylococcus coagulase-negativo foi significativamente menor no grupo mo xifloxacina, em comparação com os controles (p=0,049). Acinetobacter baumannii continuou a crescer após a administração de azitromicina (p=0,033). Quando os resultados de 4 dias após a injeção intravítrea foram avaliados, o crescimento do Staphylococcus coagulase-negativo foi maior no controle, em comparação com pacientes que receberam azitromicina ou moxifloxacina (p=0,004). A taxa de erradicação também foi significativamente maior no grupo moxifloxacina do que no grupo controle (p=0,001). As amostras obtidas no dia 8 após injeção intravítrea mostraram níveis semelhantes de crescimento bacteriano em todos os grupos (p=0,217). Conclusão: A moxifloxacina foi mais eficaz do que 5% de iodopovidona no controle do crescimento da flora bacteriana conjuntival. O uso de moxifloxacina em combinação com 5% de iodopovidona resultou em um efeito sinérgico.


Subject(s)
Humans , Povidone-Iodine/administration & dosage , Azithromycin/administration & dosage , Conjunctiva/microbiology , Intravitreal Injections/methods , Moxifloxacin/administration & dosage , Anti-Infective Agents, Local/administration & dosage , Anti-Bacterial Agents/administration & dosage , Time Factors , Acinetobacter/isolation & purification , Acinetobacter/drug effects , Conjunctivitis, Bacterial/microbiology , Conjunctivitis, Bacterial/prevention & control , Endophthalmitis/microbiology , Endophthalmitis/prevention & control , Treatment Outcome , Conjunctiva/drug effects , Escherichia coli/isolation & purification , Escherichia coli/drug effects
3.
Arq. bras. oftalmol ; 80(3): 196-198, May-June 2017. graf
Article in English | LILACS | ID: biblio-888105

ABSTRACT

ABSTRACT Fungal endophthalmitis is a rare condition often associated with poor prognosis. We present a case of postoperative acute fungal endophthalmitis caused by the yeast-like fungus Stephanoascus ciferrii (Candida ciferrii). The fungus was resistant to fluconazole, voriconazole, and amphotericin B but susceptible to caspofungin. Because the degree of vitreal penetration of caspofungin after its intravenous administration is unclear, we performed multiple intravitreal injections, first with 50 µg/0.1 ml and then with 250 µg/0.1 ml caspofungin. Despite the recurrence of symptoms, intravitreal injection of caspofungin finally abolished the inflammation and achieved ambulatory vision that persisted until 1 year of follow-up. To our knowledge, this is the first report of S. ciferrii endophthalmitis and its successful treatment with intravitreal caspofungin.


RESUMO Endoftalmite fúngica é uma ocorrência rara, muitas vezes associada com mau prog nóstico. Apresentamos um caso de endoftalmite fúngica aguda pós-operatória causada por fungo de levedura incomum, Stephanoascus ciferrii (Candida ciferrii). O fungo foi resistente ao fluconazol, ao voriconazol e à anfotericina B e susceptível à caspofun gina. Dado que a penetração vítrea da caspofungina após administração intravenosa não é clara, optou-se por realizar múltiplas injecções intravítreas, primeiro de 50 µg e depois de 250 µg de caspofungina, e finalmente obteve-se a resolução da inflamação e a visão recuperada foi mantida por pelo menos um ano após o ocorrido. No nosso conhecimento, este é o primeiro relato de endoftalmite por Stephanoascus ciferrii e o primeiro relato de endoftalmite fúngica tratada com sucesso com caspofungina intravítrea.


Subject(s)
Humans , Female , Middle Aged , Eye Infections, Fungal/drug therapy , Endophthalmitis/microbiology , Endophthalmitis/drug therapy , Echinocandins/administration & dosage , Intravitreal Injections , Antifungal Agents/administration & dosage , Vitrectomy , Visual Acuity , Reproducibility of Results , Treatment Outcome , Phacoemulsification/adverse effects , Saccharomycetales , Lipopeptides/administration & dosage , Caspofungin
4.
Arq. bras. oftalmol ; 78(4): 252-254, July-Aug. 2015. ilus
Article in English | LILACS | ID: lil-759251

ABSTRACT

ABSTRACTPostoperative fungal endophthalmitis is a rare but devastating complication of cataract surgery. Vitrectomy and intravitreal amphotericin B injection as well as administration of systemic antifungal agents have been suggested as optimal treatments for fungal endophthalmitis. However, this therapy may fail to eliminate fungal species resistant to current antifungal agents. The saprophytic fungus Trichosporon asahii is frequently observed as a cause of endogenous endophthalmitis in immunosuppressed patients. We report a case of postoperative endophthalmitis caused by T. asahii, resistant to amphotericin B. To the best of our knowledge, this is the first report of T. asahii endophthalmitis successfully treated with intravitreal and systemic voriconazole, pars plana vitrectomy, and removal of the intraocular lens and entire lens capsule.


RESUMOEndoftalmite fúngica pós-operatória é uma complicação rara mas devastadora da cirurgia de catarata. A vitrectomia e injeção intravítrea de anfotericina B, bem como agentes fungicidas sistêmicos, têm sido sugeridos como tratamentos ideais para endoftalmite fúngica. No entanto, esta terapia pode falhar em erradicar as espécies de fungos resistentes aos agentes antifúngicos atuais. Uma dessas espécies de fungos é o fungo saprófita,Trichosporon asahii, que é frequentemente observada, como causa de endoftalmite endógena, em pacientes imunodeprimidos. Relatamos um caso de endoftalmite pós-operatória causada porT. asahii que é resistente a anfotericina B. Ao nosso conhecimento, este é o primeiro relato de endoftalmite porT. asahii tratado com sucesso com voriconazol intravítreo e sistêmico, vitrectomia viapars plana, e remoção da lente intraocular e saco capsular.


Subject(s)
Aged , Humans , Male , Antifungal Agents/administration & dosage , Cataract Extraction/adverse effects , Endophthalmitis/drug therapy , Eye Infections, Fungal/drug therapy , Trichosporonosis/drug therapy , Voriconazole/administration & dosage , Endophthalmitis/microbiology , Eye Infections, Fungal/microbiology , Intravitreal Injections , Trichosporon/classification , Trichosporon/isolation & purification
5.
Biomédica (Bogotá) ; 34(supl.1): 23-33, abr. 2014. tab
Article in Spanish | LILACS | ID: lil-712418

ABSTRACT

Introducción. La resistencia bacteriana es crítica para la selección de los antibióticos en el tratamiento de las infecciones, por ello es vital conocer su estado actual en nuestro medio. Objetivo. Determinar la sensibilidad antibiótica bacteriana in vitro obtenida de los cultivos de queratitis e infecciones intraoculares. Materiales y métodos. Se llevó a cabo un estudio retrospectivo en la Fundación Oftalmológica de Santander (FOSCAL), entre junio de 2011 y enero de 2012. Resultados. Se examinaron 92 muestras. Se identificaron 110 bacterias, 27 hongos y 12 amebas de vida libre. Del total de bacterias Gram positivas, 1,1 %, 0 %, 1,1 %, 16,9 %, 29,3 % y 85 % fue resistente a imipenem, moxifloxacina, gatifloxacina, levofloxacina, ciprofloxacina y tobramicina, respectivamente, mientras que la resistencia a estos mismos fármacos se presentó, respectivamente, en 0 %, 8,3 %, 0 %, 0 %, 18,2 % y 27,3 % de las bacterias Gram negativas. Los porcentajes de resistencia de los estafilococos positivos para coagulasa resistentes a la meticilina fueron 0 %, 0 %, 0 %, 7 %, 17 % y 100 %, respectivamente, y los porcentajes de los estafilococos negativos para coagulasa resistentes a la meticilina fueron 3 %, 0 %, 0 %, 24 %, 44 % y 100 %, respectivamente. Los porcentajes de resistencia bacteriana globales (tanto para bacterias Gram positivas como para Gram negativas) a imipenem, moxifloxacina, gatifloxacina, levofloxacina, ciprofloxacina y tobramicina fueron 1 %, 1 %, 1 %, 15,1 %, 28 % y 64,5 %, respectivamente. Conclusiones. Los niveles de resistencia bacteriana para imipenem, moxifloxacina y gatifloxacina fueron menores que para levofloxacina, ciprofloxacina y tobramicina. Los niveles de resistencia para la tobramicina fueron muy altos, lo que pone en duda su utilidad clínica en las infecciones oculares en nuestro medio.


Introduction: Bacterial resistance is critical for the selection of antibiotics in the treatment of infections, so it is vital to know its current status in our geographical area. Objective: To determine in vitro antibiotic susceptibility of bacterial isolates obtained from keratitis and intraocular infections. Materials and methods: A retrospective study of microbiological tests in Fundación Oftalmológica de Santander (FOSCAL) was carried out between June, 2011, and January, 2012. Results: A total of 92 samples were examined and 110 bacteria, 27 fungi and 12 free-living amoebae were identified. Polymicrobial infections constituted 50% of the total; 1.1%, 0%, 1.1%, 16.9%, 29.3% and 85% of Gram-positive bacteria were resistant to imipenem, moxifloxacin, gatifloxacin, levofloxacin, ciprofloxacin and tobramycin, respectively, while 0%, 8.3%, 0%, 0%, 18.2% and 27.3% of Gram-negative bacteria were resistant to imipenem, moxifloxacin, gatifloxacin, levofloxacin, ciprofloxacin and tobramycin, respectively. For methicillin-resistant coagulase-positive staphylococci, resistance percentages to imipenem, moxifloxacin, gatifloxacin, levofloxacin, ciprofloxacin and tobramycin were 0%, 0%, 0%, 7%, 17% and 100%, respectively. For methicillin-resistant coagulase-negative staphylococci, resistance percentages to imipenem, moxifloxacin, gatifloxacin, levofloxacin, ciprofloxacin and tobramycin were 3%, 0%, 0%, 24%, 44% and 100%, respectively. Overall bacterial resistance to imipenem, moxifloxacin, gatifloxacin, levofloxacin, ciprofloxacin and tobramycin, for both Gram-positive and Gram-negative, was 1%, 1%, 1%, 15.1%, 28% and 64.5%, respectively. Conclusions: The levels of bacterial resistance to imipenem, moxifloxacin and gatifloxacin were lower than for levofloxacin, ciprofloxacin and tobramycin. The levels of resistance to tobramycin were very high, which calls into question its usefulness in this region of our country.


Subject(s)
Humans , Corneal Ulcer/microbiology , Drug Resistance, Multiple, Bacterial , Endophthalmitis/microbiology , Eye Infections, Bacterial/microbiology , Gram-Negative Bacteria/drug effects , Gram-Positive Bacteria/drug effects , Acanthamoeba Keratitis/epidemiology , Acanthamoeba Keratitis/microbiology , Acanthamoeba/isolation & purification , Anti-Bacterial Agents/classification , Anti-Bacterial Agents/pharmacology , Aqueous Humor/microbiology , Colombia/epidemiology , Cornea/microbiology , Corneal Ulcer/drug therapy , Corneal Ulcer/epidemiology , Disk Diffusion Antimicrobial Tests , Endophthalmitis/drug therapy , Endophthalmitis/epidemiology , Eye Infections, Bacterial/drug therapy , Eye Infections, Bacterial/epidemiology , Eye Infections, Fungal/epidemiology , Eye Infections, Fungal/microbiology , Eye Infections, Parasitic/epidemiology , Eye Infections, Parasitic/parasitology , Foundations , Fluoroquinolones/pharmacology , Fungi/isolation & purification , Gram-Negative Bacteria/isolation & purification , Gram-Positive Bacteria/isolation & purification , Retrospective Studies , Vitreous Body/microbiology
6.
MEAJO-Middle East African Journal of Ophthalmology. 2014; 21 (1): 40-43
in English | IMEMR | ID: emr-139600

ABSTRACT

Listeria monocytogenes is an aerobic, motile, gram positive bacillus recognized as an intercellular pathogen in human where it most frequently affects neonates, pregnant women, elderly patients, and immunosuppressed individuals as well as healthy persons. Ocular listeriosis is rare, most frequently in the form of conjunctivitis, but has been also shown to cause rarely endophthalmitis with pigmented hypopyon and elevated intraocular pressure such as in our case. We are reporting one immunocompetent patient presenting with dark hypopyon following laser refractive procedure. His clinical findings, investigations, and further management are all described with relevant literature review of similar cases. Diagnosis of ocular listeriosis was confirmed by positive culture of anterior chamber [AC] aspirate with identification of the above organism. His visual outcome was satisfactory with good preserved vision. We believe that his ocular infection was exogenous and that ophthalmologists should be aware of the causative organisms of colored hypopyon to avoid delayed diagnosis


Subject(s)
Humans , Male , Endophthalmitis/microbiology , Listeriosis/pathology , Listeria monocytogenes/pathogenicity , Intraocular Pressure , Review Literature as Topic , Refractive Surgical Procedures , Pigment Epithelium of Eye/microbiology , Ocular Hypertension/microbiology , Eye Infections, Bacterial , Anterior Chamber/pathology
8.
Rev. chil. infectol ; 30(5): 516-521, oct. 2013. tab
Article in Spanish | LILACS | ID: lil-691158

ABSTRACT

Endogenous endophthalmitis (EE) is a prevalent but serious disease. Our aim was to describe cases of EE, with emphasis in the risk factors and the improvement of the prognosis. Methods: A review of EE cases was done between 1996-2011 in a secondary care hospital in Spain. The reported variables were: comorbidities, isolated microorganisms, susceptibility to antimicrobial treatment and visual prognosis. Results: 9 cases of EE were analyzed. All had some underlying disease, diabetes mellitus being the most frequent. Seven of the nine cases had a history of eye injury. Extraocular source of infection was identified in 7 cases, with predominantly gastrointestinal disease. Most microorganisms were isolated from blood cultures. The visual prognosis was unfavorable in five patients and was associated with virulent microorganisms and delayed treatment. Conclusions: EE is a rare disease that involve immunocompromised patients with ophthalmic disease. To improve prognosis, appropriate diagnosis and early treatment is require. Therefore, we recommend funduscopy examination in patients with sepsis, risk factors and prior history of ocular disease.


La endoftalmitis endógena (EE) es una patología poco prevalente aunque grave. Nuestro objetivo es describir los casos de EE diagnosticados en un hospital secundario español, con particular atención a los factores de riesgo y la posible mejora del pronóstico. Material y Métodos: Revisamos las historias clínicas de los pacientes diagnosticados de EE entre 1996-2011. Las variables recogidas fueron: co-morbilidades, microorganismo/s aislados y su susceptibilidad a los antimicrobianos, tratamiento administrado y pronóstico visual. Resultados: Se estudiaron nueve casos de EE. Todos presentaban alguna enfermedad de base, siendo diabetes mellitus la más frecuente. Siete de los nueve casos presentaron antecedentes de lesión ocular. La probable fuente extraocular se identificó en siete casos, predominando el foco gastrointestinal. La mayoría de microorganismos se aisló de hemocultivos. El pronóstico visual fue desfavorable en cinco pacientes, asociándose a microorganismos virulentos y al retraso terapéutico. Conclusiones: La EE es una enfermedad inusual que afecta a pacientes con inmunidad disminuida y antecedentes oftalmológicos. Para mejorar el pronóstico se requiere un diagnóstico acertado y un tratamiento precoz, todo un reto para médicos clínicos y microbiólogos. Por ello, recomendamos realizar un fondo de ojo a los pacientes con sepsis, factores de riesgo de EE y antecedentes de patología ocular.


Subject(s)
Adolescent , Adult , Aged , Aged, 80 and over , Child , Child, Preschool , Female , Humans , Infant , Male , Middle Aged , Young Adult , Endophthalmitis/microbiology , Endophthalmitis/complications , Endophthalmitis/drug therapy , Prognosis , Retrospective Studies , Risk Factors , Severity of Illness Index
9.
Article in English | IMSEAR | ID: sea-157503

ABSTRACT

Objective: To evaluate the efficacy and safety of intracameral Moxoft eye drops (Moxifloxacin ophthalmic solution 0.5%) administered at the conclusion of phacoemulsification cataract surgery for the purpose of endophthalmitis prophylaxis. Design: Open label, multicentre, prospective. Setting: Three ophthalmologists across India. Methods: A total of 134 outpatients of either sex undergoing phacoemulsification with no ocular pathology other than cataract and meeting all inclusion/exclusion criteria were enrolled in the study. All patients received preoperatively 1 drop of Moxoft eye drops (Moxifloxacin ophthalmic solution 0.5%) topically every 15 minutes atleast 4 times one hour prior to surgery. 0.1 ml moxifloxacin solution was aspirated into the tuberculin syringe and injected into the capsular bag under the capsulorhexis edge after completion of the Phacoemulsification and IOL implantation. Post-operative treatment was as per standard protocol. Patients were assessed pre-operatively and on day 1, day 7 & day 30 after surgery for ocular symptom scores for pain in eyes, ocular discharge, hazy cornea, conjunctival hyperemia, and hypopyon and chemosis. Anterior chamber (AC) reaction was graded (if present) on all the visits with fixed slit-lamp settings and on 5-point rating scale for AC flare and cells in AC. Global assessment was done for efficacy and tolerability at the end of therapy on a 3-point scale. Result: Thirteen patients were excluded from the analysis due to insufficient data and an intentionto- treat analysis was done for efficacy on 121 patients. There was significant reduction in scores of pain in eyes, conjunctival hyperemia, mean AC flare, mean AC cells (p<0.0001 for all) and ocular discharge (p=0.018). Hypopyon and/or corneal endothelial cell damage was observed in none of the patients. Therapy was rated good to excellent on efficacy and tolerability parameters with no reporting of a poor rating. Conclusion: Moxoft eye drops (Moxifloxacin ophthalmic solution 0.5%) is safe for use by intracameral administration with no corneal decompensation. Tolerability and post-operative results were found to be excellent.


Subject(s)
Anterior Chamber/drug effects , Antibiotic Prophylaxis , Cataract/drug therapy , Cataract/surgery , Cataract Extraction , Endophthalmitis/microbiology , Endophthalmitis/prevention & control , Female , Fluoroquinolones/administration & dosage , Fluoroquinolones/therapeutic use , Humans , Male , Ophthalmic Solutions/administration & dosage , Ophthalmic Solutions/therapeutic use
10.
Arq. bras. oftalmol ; 75(5): 344-347, set.-out. 2012. ilus, tab
Article in English | LILACS | ID: lil-667580

ABSTRACT

PURPOSE: To describe an outbreak of Pseudomonas aeruginosa endophthalmitis post cataract surgery. Clinical findings, treatment and outcome are discussed. METHODS: Clinical charts review of forty-five patients treated for endophthalmitis in a two-day period. The patients underwent primary vitrectomy, anterior chamber irrigation and intravitreous antibiotic injection. Cultures from vitreous and anterior chamber samples were performed in all patients. RESULTS: Forty-five patients (twenty-three men and twenty-two women) were identified. The average age was 71.2 years (range, 56-83 years). The right eye (62%) was affected more often than the left eye (38%). The median interval between surgery and endophthalmitis onset was 5.5 days (range, 5-6 days). The visual acuity at the diagnosis was better than 20/40 in one patient (2%), from 20/40 to 20/200 in one patient (2%), from 20/400 to counting fingers in two patients (4%), hand movements in eleven patients (24%), and light perception in thirty patients (68%). Pseudomonas aeruginosa was the isolated agent in twenty-six vitreous samples and in three anterior chamber samples. Overall, one patient (2%) achieved a final visual acuity better than 20/40; eight patients (18%) achieved a final visual acuity from 20/40 to 20/200; six patients (13%) achieved a final visual acuity from 20/400 to counting fingers; eleven patients (25%) achieved a final acuity of hand movements; thirteen patients (29%) achieved a final acuity of light perception and six (13%) patients had no light perception at the last examination. None of these eyes underwent evisceration or enucleation in a three-month follow-up period. CONCLUSION: Even with all the safety that cataract surgery has achieved, today, endophthalmitis remains a risk and a fearful complication of this procedure. In the present study, it was impossible to identify the source of the outbreak.


OBJETIVO: Descrever surto de endoftalmite por Pseudomonas aeruginosa após facectomia. Os achados clínicos, o tratamento e o resultado são discutidos. MÉTODOS: Revisão dos prontuários de quarenta e cinco pacientes tratados para endoftalmite em um período de dois dias. Todos os pacientes foram tratados por vitrectomia primária, irrigação da câmara anterior e injeção vítrea de antibióticos. Culturas do vítreo e de amostras de câmara anterior foram realizadas em todos os pacientes. RESULTADOS: Quarenta e cinco pacientes (23 homens e 22 mulheres) foram identificados. A idade média foi 71,2 anos (variação, 56-83 anos). O olho direito (62%) foi mais afetado do que o esquerdo (38%). O intervalo médio entre a cirurgia e a apresentação da endoftalmite foi de 5,5 dias (intervalo de 5-6 dias). A acuidade visual no momento do diagnóstico foi melhor que 20/40 em um paciente (2%), de 20/40 a 20/200 em um paciente (2%), de 20/400 para contar dedos em dois pacientes (4%), movimento de mão em onze pacientes (24%), percepção de luz em trinta pacientes (68%). Pseudomonas aeruginosa foi o agente isolado em 26 amostras de vítreo e em três amostras da câmara anterior. No geral, um paciente (2%) obteve acuidade visual final melhor que 20/40, oito pacientes (18%) obtiveram acuidade visual final de 20/40 a 20/200, seis pacientes (13%) obtiveram acuidade visual final de 20/400 para contar os dedos; onze pacientes (25%) obtiveram acuidade visual final de movimento de mão; treze pacientes (29%) obtiveram acuidade visual final de percepção de luz e seis (13%) pacientes não havia percepção luminosa no último exame. Nenhum olho foi submetido à evisceração ou enucleação em três meses de acompanhamento. CONCLUSÃO: Mesmo com toda a segurança da cirurgia de catarata nos dias atuais, endoftalmite permanece um risco e uma complicação temível deste procedimento. No presente estudo não foi possível identificar a fonte do surto.


Subject(s)
Aged , Aged, 80 and over , Female , Humans , Male , Middle Aged , Disease Outbreaks , Endophthalmitis/epidemiology , Eye Infections, Bacterial/epidemiology , Phacoemulsification/adverse effects , Pseudomonas Infections/epidemiology , Endophthalmitis/microbiology , Eye Infections, Bacterial/microbiology , Pseudomonas aeruginosa/isolation & purification , Retrospective Studies , Visual Acuity , Vitrectomy
11.
Arq. bras. oftalmol ; 75(2): 89-91, mar.-abr. 2012. ilus
Article in English | LILACS | ID: lil-640152

ABSTRACT

PURPOSE: To analyze the antimicrobial properties of silicon oil (Óleo de Silicone®, Ophthalmos, Brazil) on in vitro bacterial growth of different microorganisms related to endophthalmitis. METHODS: The following microorganisms were analyzed: (1) Pseudomonas aeruginosa (ATCC 27583); (2) Escherichia coli (ATCC 25922); (3) Staphylococcus aureus (ATCC 25923); (4) Staphylococcus epidermidis (ATCC 12228); (5) Candida albicans (ATCC 10231); (6) Klebsiella pneumoniae (ATCC 13883); and (7) Streptococcus pneumoniae (ATCC 49619). The plates were incubated at 35 ± 2ºC and its growth examined after 24 hours. An empty disk was placed in the center of each plate as a control. RESULTS: No inhibition halos were verified in any of the plates containing the four different concentrations of the bacterial inocula. CONCLUSIONS: The silicon oil 1000 cps does not have any effect on bacterial growth of any of the studied microrganisms.


OBJETIVO: Analisar as propriedades antimicrobianas do óleo de silicone (Óleo de Silicone®, Ophthalmos, Brazil) no crescimento in vitro de diferentes microrganismos relacionados à endoftalmite. MÉTODOS: Os seguintes microrganismos foram analisados: (1) Pseudomonas aeruginosa (ATCC 27583); (2) Escherichia coli (ATCC 25922); (3) Staphylococcus aureus (ATCC 25923); (4) Staphylococcus epidermidis (ATCC 12228); (5) Candida albicans (ATCC 10231); (6) Klebsiella pneumoniae (ATCC 13883); and (7) Streptococcus pneumoniae (ATCC 49619). As placas foram incubadas à temperatura de 35 ± 2ºC e o seu crescimento examinado após 24 horas. Um disco de papel filtro neutro, sem óleo de silicone, foi posicionado no centro de cada placa como controle. RESULTADOS: Não foram encontrados halos de inibição em nenhuma das placas contendo as diferentes concentrações de inóculo bacteriano estudadas. CONCLUSÕES: O Óleo de Silicone® 1000 cps não apresenta efeito no crescimento bacteriano de nenhum dos microrganismos estudados.


Subject(s)
Humans , Anti-Infective Agents/pharmacology , Candida albicans/drug effects , Endophthalmitis/microbiology , Gram-Negative Bacteria/drug effects , Gram-Positive Bacteria/drug effects , Silicone Oils/pharmacology , Candida albicans/growth & development , Gram-Negative Bacteria/growth & development , Gram-Positive Bacteria/growth & development , Microbial Sensitivity Tests
12.
Indian J Ophthalmol ; 2012 Jan; 60(1): 41-44
Article in English | IMSEAR | ID: sea-138787

ABSTRACT

Aim: To compare the bacterial contamination of the anterior chamber (AC) between manual small incision cataract surgery (SICS) and phacoemulsification (Phaco). To study the conjunctival flora and bacterial contamination of AC between well-controlled diabetics and non-diabetics. Materials and Methods: Three hundred and sixty-eight patients were randomized to manual SICS and Phaco. Sixty-eight patients were excluded for not completing follow-up or for intraoperative complications like posterior capsule rupture. One hundred and fifty patients in each group were finally analyzed. Conjunctival swabs were taken on admission, after one day of topical ofloxacin and 15 min after 5% Povidone Iodine (PI) instillation. AC aspirate at the end of the surgery was also cultured. Results: Fifty-six (18.66%) patients had positive conjunctival swab on admission which was reduced to 19 (6.33%) with topical ofloxacin and to five (1.66%) with instillation of 5% PI. AC contamination in both manual SICS and Phaco was 0.66%. The conjunctival flora in diabetics was similar to non-diabetics. None of the diabetics had AC contamination. Statistical analysis was performed by Chi-Square test (with Yates’ correction). Conclusion: Statistically significant reduction in conjunctival flora was achieved with topical ofloxacin and 5% PI instillation and AC contamination in both manual SICS and Phaco was minimal (0.66%). Well-controlled diabetics who underwent cataract surgery in this study had similar conjunctival flora and AC contamination as non-diabetics.


Subject(s)
Adult , Anterior Chamber/microbiology , Anterior Chamber/pathology , Anterior Chamber/surgery , Bacteria/isolation & purification , Cataract Extraction/methods , Diabetes Complications/complications , Endophthalmitis/etiology , Endophthalmitis/microbiology , Eye Infections, Bacterial/etiology , Eye Infections, Bacterial/microbiology , Follow-Up Studies , Humans , Retrospective Studies , Surgical Wound Infection/etiology , Surgical Wound Infection/microbiology
13.
SJO-Saudi Journal of Ophthalmology. 2011; 25 (3): 231-238
in English | IMEMR | ID: emr-129875

ABSTRACT

To review the clinical experience of fungal keratitis cases at King Khaled Eye Specialist Hospital [KKESH] in Riyadh, Saudi Arabia. Retrospective observational review and analysis of 124 patient charts with confirmed diagnosis of fungal keratitis between 1984 and 2004. One hundred and twenty four eyes of 124 patients had proven fungal infection; 101 eyes had fungal keratitis and 23 eyes had fungal endophthalmitis complicating keratitis. Estimated proportion of fungal keratitis and endophthalmitis was 10.3%. Mean age was 55 years with male predominance [79.0%]. Commonly associated factors were previous intraocular surgery [38.7%] and trauma [20.9%]. Major risk factor for progressing to endophthalmitis was previous intraocular surgery [65.2%], p < 0.001. Initial laboratory results were fungal positive only in 30.6% [p < 0.001]. Commonest organisms isolated were Aspergillus spp. [29.8%] followed by Trichophyton sp. [16.1%], then Candida and Fusarium sp. Comparison of both phases of the study showed improvement in the rate of successfully treated cases from 34.6% to 58.3%, and a decline in cases progressing to endophthalmitis from 25.0% to 13.9%. Therapeutic penetrating keratoplasty increased from 26.9% to 73.6% [p < 0.001]. Thirteen eyes required enucleation or evisceration. In contrast to other studies on fungal keratitis, Aspergillus spp. and Trichophyton sp. were the most commonly isolated fungal pathogens; the former carries the worst prognosis. Risk factors included previous intraocular surgery and trauma. Poor outcome was associated with Aspergillus spp., delayed presentation, previous intraocular surgery and late surgical intervention. This study recommends early surgical intervention to improve the outcome


Subject(s)
Humans , Aged , Aged, 80 and over , Male , Female , Middle Aged , Child, Preschool , Child , Adolescent , Adult , Keratitis/microbiology , Endophthalmitis/microbiology , Eye Infections, Fungal/complications , Eye Infections, Fungal/etiology , Eye Infections, Fungal/microbiology , Aspergillosis/epidemiology , Risk Factors , Retrospective Studies
14.
Arq. bras. oftalmol ; 73(6): 505-507, nov.-dez. 2010. tab
Article in English | LILACS | ID: lil-572213

ABSTRACT

Purpose: To report on the incidence, diagnostic technique, and microbiological features of endophthalmitis at a university-setting in Brazil. Methods: All cases of presumed postoperative endophthalmitis from 2002 to 2008 at a teaching-hospital were included. Main data assessed were: number of cataract surgeries performed, incidence of endophthalmitis, microbiological outcome (aqueous and/or vitreous culture and Gram staining), and antimicrobial susceptibility testing of the positive cases. Results: Seventy-three eyes of 73 patients (43 females and 30 males) developed endophthalmitis after 24,590 cataract surgeries. The incidence decreased from 0.49 percent in 2003 to 0.17 percent in 2006 and stabilized afterwards. Coagulase negative Staphylococci (CoNS) and Streptococcus viridans (56.5 percent and 15 percent, respectively) were the most common bacterial isolates. Culture and Gram stain were negative in 36.9 percent. CoNS presented susceptibility rates of 80 percent-sensitivity to oxacillin, 90 percent to fourth-generation quinolones and 100 percent to vancomycin. Conclusions: The rate of endophthalmitis, diagnostic ability of conventional laboratory investigation, microbial isolates and antibiotic susceptibility are in accordance with other findings of the literature. Despite using prophylactic antibiotic drops, it was possible to identify cases that were susceptible to the antibiotics topically applied.


Objetivo: Relatar incidência, técnica diagnóstica e características microbiológicas de endoftalmite numa instituição universitária no Brasil. Métodos: Todos os casos de endoftalmite pós-operatória presumida de 2002 a 2008 foram incluídos. Os principais dados avaliados foram: número de cirurgias de catarata realizadas, incidência de endoftalmite, resultado microbiológico (bacterioscopia e cultura de aquoso e vítreo) e teste de sensibilidade antibiótica dos casos positivos. Resultados: Setenta e três olhos de 73 pacientes (43 do sexo feminino e 30 do masculino) desenvolveram endoftalmite após 24.590 cirurgias de catarata. A incidência reduziu de 0,49 por cento em 2003 para 0,17 por cento em 2006 e estabilizou-se depois disso. Staphylococcus coagulase-negativa (SCoN) e Streptococcus viridans (56.5 por cento e 15 por cento, respectivamente) foram os isolados bacterianos mais comuns. Cultura e bacterioscopia foram negativas em 36,9 por cento. SCoN apresentou taxas de sensibilidade de 80 por cento à oxacilina, 90 por cento às quinolonas de quarta geração e 100 por cento à vancomicina. Conclusões: A taxa de endoftalmite, a capacidade diagnóstica das técnicas laboratoriais convencionais, os microrganismos isolados e a sensibilidade aos antibióticos estão em acordo com outros achados na literatura. Apesar do uso profilático de colírio antibiótico, foi possível identificar casos de infecção em que as bactérias eram sensíveis aos antibióticos usados topicamente.


Subject(s)
Aged , Female , Humans , Male , Middle Aged , Cataract Extraction/adverse effects , Endophthalmitis/epidemiology , Bacteria/isolation & purification , Brazil/epidemiology , Endophthalmitis/microbiology , Hospitals, University , Incidence , Microbial Sensitivity Tests , Treatment Outcome
15.
Indian J Ophthalmol ; 2010 Jul; 58(4): 297-302
Article in English | IMSEAR | ID: sea-136075

ABSTRACT

Background: The objective of the study was the determination of the incidence of culture-proven postoperative endophthalmitis and probable sources of infection. Materials and Methods: It was a prospective study on the microbiology, incidence and probable sources of infection in patients with postoperative infectious endophthalmitis carried out in a tertiary care eye hospital. Consecutive patients diagnosed with postoperative infectious endophthalmitis during the years 2000-2007 were investigated for the causative infective agent and possible sources of infection. The surgical data and microbiological data including the investigations performed to trace the source were recorded in a specific formatted form and were gathered and compiled for analysis. Results: Data of analysis showed that 98 (0.042%) out of 2,31,259 patients who underwent intra-ocular surgery developed infectious endophthalmitis. Among these, 70 (0.053%) occurred after cataract, 10 (0.5%) after penetrating keratoplasty (PK) and 18 (0.018%) following other types of intra-ocular surgeries. The predominant infectious agents isolated were bacteria (89.7%), with equal proportions of Gram-positive and Gram-negative bacteria. Polymicrobial infection was noted in four and fungi in seven patients. Occurrence of postoperative endophthalmitis was sporadic and not related to any specific part of period in a year. Sources of infection were donor corneal rim in six post-PK patients and phaco probe in one who had postphacoemulsification endophthalmitis Conclusions: Overall incidence of postoperative endophthalmitis over an 8-year period was quite low. The sources of infection could be established in six post-PK endophthalmitis patients and in a postcataract surgery.


Subject(s)
Cataract Extraction/statistics & numerical data , Endophthalmitis/epidemiology , Endophthalmitis/microbiology , Endophthalmitis/surgery , Follow-Up Studies , Geobacillus stearothermophilus , Gram-Positive Bacterial Infections/epidemiology , Gram-Positive Bacterial Infections/surgery , Hospitals, Special/statistics & numerical data , Humans , India/epidemiology , Postoperative Complications/epidemiology , Postoperative Complications/microbiology , Retinal Diseases/surgery , Time Factors , Vitreous Body/surgery
16.
Article in English | IMSEAR | ID: sea-135483

ABSTRACT

Background & objectives: Though not frequently but there are reports showing phacoemulsifiers as a potent source of infection in post-operative cases of endophthalmitis. This study was carried out to find antibiogram and genetic relatedness between Pseudomonas aeruginosa isolates from a post-cataract surgery endophthalmitis outbreak (3 patients) and internal tubings of 5 phacoemulsifiers. Methods: In vitro antimicrobial sensitivity patterns of the 8 bacterial isolates were observed. Genetic analysis of the bacterial isolates was done using random amplification of polymorphic DNA (RAPD) assay and PCR ribotyping. The resulting DNA band patterns were examined visually and by computer assisted analysis using unweighted pair group method. Results: The three P. aeruginosa patient isolates were found to be different from the five phacoemulsifier isolates in sensitivity towards 3 antibiotics and by genetic analysis (33 and 44% homology by RAPD assay and PCR ribotyping). Two of the patient isolates shared 100 per cent genetic homology by RAPD assay and another pair shared 100 per cent homology by PCR ribotyping. The five isolates from phacoemulsifiers did not share significant genetic homology. There was significant genetic variation between bacterial isolates from patients and phaco emulsifiers. Interpretation & conclusion: Though the three P. aeruginosa isolates obtained from the patients were phenotypically similar and genetically close, they differed from the phaco-machine isolates both genetically, and in their antibiogram profile. However, the five phacoemulsifier isolates were genetically diverse though they shared the same antibiogram profile. Therefore the Ringer’s lactate from phacomachines could not be conclusively proven to be the source of infection.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Electrophoresis, Agar Gel , Endophthalmitis/drug therapy , Endophthalmitis/microbiology , Humans , Phacoemulsification , Postoperative Complications , Pseudomonas aeruginosa/genetics , Pseudomonas aeruginosa/isolation & purification
17.
Korean Journal of Ophthalmology ; : 279-283, 2010.
Article in English | WPRIM | ID: wpr-127990

ABSTRACT

PURPOSE: To assess the results and long-term prognosis of evisceration with primary porous implant placement in patients with endophthalmitis. METHODS: A retrospective study was conducted to review the files of 27 patients (29 eyes) with endophthalmitis who underwent evisceration with primary porous implant placement from January 1997 to December 2007 at St. Mary's Hospital and Kangnam St. Mary's Hospital. The mean follow-up period was 12.24 months (range, 3 to 89 months) and the mean age of the patients was 63.6 years (range, 33 to 89 years). RESULTS: During the surgical procedure, primary implant placement was successfully completed, and any postoperative infection or inflammation rapidly resolved in all 27 patients (29 eyes). One of two porous implant materials was used. Hydroxyapatite was inserted in 14 eyes and Medpor was inserted in 15 eyes. Delayed implant exposure was noted in 1 eye, which was treated by inserting a hydroxyapatite implant 18 months after the first surgery. This was well treated by a preserved scleral graft. Implant infection was noted in 1 other eye at 20 days after the first surgery. All other minor complications healed without sequelae. CONCLUSIONS: Evisceration with primary porous implant placement as the treatment for recalcitrant endophthalmitis resulted in rapid resolution of any infection and inflammation. Implant exposure and infection occurred in only 2 eyes, and these problems were well treated without long-term sequelae. Therefore, evisceration with primary porous implant placement is a treatment option for patients with endophthalmitis.


Subject(s)
Adult , Aged , Aged, 80 and over , Female , Humans , Male , Middle Aged , Endophthalmitis/microbiology , Eye Evisceration , Orbital Implants , Porosity , Prognosis , Retrospective Studies , Treatment Outcome
19.
Indian J Ophthalmol ; 2009 Jul; 57(4): 306-308
Article in English | IMSEAR | ID: sea-135966

ABSTRACT

Endogenous fungal endophthalmitis is most commonly caused by Candida species and usually occurs in patients with chronic diseases such as diabetes mellitus and renal insufficiency. Voriconazole, a broad-spectrum triazole antifungal agent, attains therapeutically significant concentrations in the vitreous cavity after systemic administration. We report, the successful management of presumed endogenous Candida endophthalmitis in a patient with multiple diseases and unstable systemic status with oral voriconazole. Though fungal endophthalmitis has been successfully treated with a combination of intravenous and intravitreal voriconazole, to the best of our knowledge this is the first report in ophthalmic literature (Medline Search) on the treatment of fungal endophthalmitis with only the oral route of administration of voriconazole.


Subject(s)
Administration, Oral , Aged , Antifungal Agents/administration & dosage , Candidiasis/drug therapy , Endophthalmitis/metabolism , Endophthalmitis/microbiology , Endophthalmitis/pathology , Exudates and Transudates/drug effects , Exudates and Transudates/metabolism , Humans , Male , Pyrimidines/administration & dosage , Treatment Outcome , Triazoles/administration & dosage , Vitreous Body/drug effects , Vitreous Body/metabolism , Vitreous Body/pathology
20.
Indian J Med Sci ; 2009 June; 63(6) 253-256
Article in English | IMSEAR | ID: sea-145415

ABSTRACT

In this report, we describe a patient with drug-induced liver failure who developed endogenous endophthalmitis after liver transplantation. Our patient's clinical course was so fulminant that the eye was lost in less than 1 month, without any response to therapy. Recognition of this infection is important because many patients die of disseminated Aspergillus infection, which may be detected early with bedside funduscopic examination by an ophthalmologist. Probably if the patient had referred to us earlier, it may have been possible to save the eye.


Subject(s)
Amphotericin B/therapeutic use , Anti-Bacterial Agents/therapeutic use , Antifungal Agents/therapeutic use , Aspergillosis/diagnosis , Aspergillosis/drug therapy , Aspergillosis/microbiology , Aspergillosis/surgery , Aspergillus/isolation & purification , Ceftazidime/therapeutic use , Endophthalmitis/diagnosis , Endophthalmitis/drug therapy , Endophthalmitis/microbiology , Endophthalmitis/surgery , Eye/microbiology , Eye/pathology , Eye/diagnostic imaging , Humans , Immunosuppression Therapy/adverse effects , Liver Transplantation/adverse effects , Liver Transplantation/methods , Male , Ophthalmologic Surgical Procedures , Ophthalmoscopy , Transplantation, Homologous/adverse effects , Transplantation, Homologous/methods , Vancomycin/therapeutic use , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL